SURUNKALI GEPATIT B DAVOLASH PROFILAKTIKASI

Authors

  • Musajonov Nurillo Mansurbek o’gli Qo’qon universiteti andijon filiali Davolsh ishi yo’nalishi 24-11 guruh talabasi

Keywords:

Surunkali gepatit B, gepatit B virusi, , jigar yallig‘lanishi, jigar sirrozi, gepatosellyulyar karsinoma, , virus replikatsiyasi, antiviral davolash, interferon, tenofovir, entekavir, profilaktika, emlash, jigar yetishmovchiligi.

Abstract

Surunkali gepatit B — bu gepatit B virusi bilan uzoq muddatli infeksiya natijasida jigar to‘qimalarining yallig‘lanishi bilan kechadigan kasallikdir. Kasallik odatda virus bilan yuqtirgandan so‘ng 6 oydan ortiq davom etuvchi infeksiya holatida rivojlanadi. Surunkali gepatit B butun dunyoda sog‘liqni saqlash uchun muhim muammo bo‘lib, jigar sirrozi va gepatosellyulyar karsinoma (jigar saratoni)ning asosiy sabablaridan biridir.Klinik belgilari ko‘pincha sust kechadi: umumiy holsizlik, ishtaha yo‘qolishi, qorinda og‘irlik, ko‘ngil aynishi, ba’zan sariqlik kuzatiladi. Bemorlarning ko‘pchiligida kasallik simptomsiz kechib, faqat laborator tahlillar orqali aniqlanadi. Tashxis qo‘yishda serologik markerlar muhim ahamiyatga ega.Davolashning asosiy maqsadi — virus replikatsiyasini to‘xtatish, jigar shikastlanishini kamaytirish va asoratlarning oldini olishdir. Buning uchun interferonlar va nukleozid analoglari qo‘llaniladi. Shuningdek, bemorlar sog‘lom turmush tarzini olib borishlari, spirtli ichimliklardan voz kechishlari hamda muntazam nazoratda bo‘lishlari zarur.Profilaktika choralari ichida eng samaralisi — gepatit B ga qarshi emlash bo‘lib, bu kasallikning oldini olishda yuqori darajada himoya beradi.

References

World Health Organization (WHO). Hepatitis B: Key Facts. Geneva: WHO, 2024. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b

European Association for the Study of the Liver (EASL). EASL 2017 Clinical Practice Guidelines on the Management of Hepatitis B Virus Infection. Journal of Hepatology, 2017; 67(2): 370–398.

Lok, A. S. F., & McMahon, B. J. Chronic Hepatitis B: Update 2019. Hepatology, 2019; 67(4): 1560–1599.

Terrault, N. A., et al. Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2023 Practice Guidance. Hepatology, 2023; 78(1): 122–146.

O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi. Virusli gepatitlar profilaktikasi va davosi bo‘yicha klinik protokollar. Toshkent, 2022.

Abdukarimov A., Raximova N., & To‘xtaboev S. Infeksion kasalliklar. – Toshkent: “Ibn Sino” nashriyoti, 2021.

Papatheodoridis, G. V., et al. Optimal Management of Chronic Hepatitis B Infection: Challenges and Future Directions. Liver International, 2022; 42(3): 463–475.

Lavanchy, D. Hepatitis B Virus Epidemiology, Disease Burden, Treatment, and Current and Emerging Prevention and Control Measures. Journal of Viral Hepatitis, 2021; 28(6): 882–896.

Published

2026-01-30

Issue

Section

Articles